Literature DB >> 11369666

Resting and activated endothelial cells are increased in the peripheral blood of cancer patients.

P Mancuso1, A Burlini, G Pruneri, A Goldhirsch, G Martinelli, F Bertolini.   

Abstract

Circulating endothelial cells (CECs) were enumerated in 20 healthy controls and 76 newly diagnosed cancer patients by means of 4-color flow cytometry. In breast cancer (n = 46) and lymphoma (n = 30) patients, both resting and activated CECs were increased by 5-fold (P <.0008 vs control). CECs significantly correlated with plasma levels of vascular cell adhesion molecule-1 and vascular endothelial growth factor. Resting and activated CECs were similar to healthy controls in 7 lymphoma patients achieving complete remission after chemotherapy, and activated CECs were found to decrease in 13 breast cancer patients evaluated before and 24 hours after quadrantectomy. (Blood. 2001;97:3658-3661)

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11369666     DOI： 10.1182/blood.v97.11.3658

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  109 in total

1.  Effects of recombinant human endostatin and its synergy with cisplatin on circulating endothelial cells and tumor vascular normalization in A549 xenograft murine model.

Authors:  Na Li; Dawei Zheng; Xiyin Wei; Ziliang Jin; Cuicui Zhang; Kai Li
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-10       Impact factor: 4.553

Review 2.  Endothelial progenitor cells: current issues on characterization and challenging clinical applications.

Authors:  Thomas Resch; Andreas Pircher; Christian M Kähler; Johann Pratschke; Wolfgang Hilbe
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

3.  Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancer.

Authors:  Mariangela Manzoni; Sara Mariucci; Sara Delfanti; Bianca Rovati; Monica Ronzoni; Fotios Loupakis; Silvia Brugnatelli; Carmine Tinelli; Eugenio Villa; Alfredo Falcone; Marco Danova
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-15       Impact factor: 4.553

Review 4.  Circulating biomarkers in advanced renal cell carcinoma: clinical applications.

Authors:  Maria Hernandez-Yanez; John V Heymach; Amado J Zurita
Journal:  Curr Oncol Rep       Date:  2012-06       Impact factor: 5.075

5.  Flow cytometric identification and functional characterization of immature and mature circulating endothelial cells.

Authors:  Julie A Mund; Myka L Estes; Mervin C Yoder; David A Ingram; Jamie Case
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-01-26       Impact factor: 8.311

6.  Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agent.

Authors:  Sang Joon Shin; Jee Won Hwang; Joong Bae Ahn; Sun Young Rha; Jae Kyung Roh; Hyun Cheol Chung
Journal:  Invest New Drugs       Date:  2012-04-27       Impact factor: 3.850

7.  Circulating endothelial cells in essential thrombocythemia and polycythemia vera: correlation with JAK2-V617F mutational status, angiogenic factors and coagulation activation markers.

Authors:  Jacek Treliński; Agnieszka Wierzbowska; Anna Krawczyńska; Agata Sakowicz; Tadeusz Pietrucha; Piotr Smolewski; Tadeusz Robak; Krzysztof Chojnowski
Journal:  Int J Hematol       Date:  2010-05-15       Impact factor: 2.490

Review 8.  Thrombosis in Philadelphia negative classical myeloproliferative neoplasms: a narrative review on epidemiology, risk assessment, and pathophysiologic mechanisms.

Authors:  Somedeb Ball; Kyaw Zin Thein; Abhishek Maiti; Kenneth Nugent
Journal:  J Thromb Thrombolysis       Date:  2018-05       Impact factor: 2.300

9.  Circulating endothelial cells and circulating endothelial precursor cells in patients with osteosarcoma.

Authors:  Steven G DuBois; Diana Stempak; Bing Wu; Reza Bayat Mokhtari; Rakesh Nayar; Katherine A Janeway; Robert Goldsby; Holcombe E Grier; Sylvain Baruchel
Journal:  Pediatr Blood Cancer       Date:  2011-02-11       Impact factor: 3.167

10.  Incorporation of endothelial progenitor cells into the neovasculature of malignant glioma xenograft.

Authors:  Hua-rong Zhang; Fei-lan Chen; Chen-ping Xu; Yi-fang Ping; Qing-liang Wang; Zi-qing Liang; Ji Ming Wang; Xiu-wu Bian
Journal:  J Neurooncol       Date:  2008-12-04       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.